4//SEC Filing
McGreivy Jesse 4
Accession 0001209191-13-029935
CIK 0000949699other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 8:02 PM ET
Size
12.5 KB
Accession
0001209191-13-029935
Insider Transaction Report
Form 4
McGreivy Jesse
VP, Clinical Science
Transactions
- Exercise/Conversion
Common Stock
2013-05-31$25.33/sh+9,479$240,103→ 9,479 total - Exercise/Conversion
Common Stock
2013-05-31$61.60/sh+5,000$308,000→ 14,479 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-05-31−9,479→ 25,521 totalExercise: $25.33From: 2012-04-16Exp: 2022-04-16→ Common Stock (9,479 underlying) - Sale
Common Stock
2013-05-31$91.13/sh−14,479$1,319,510→ 0 total - Exercise/Conversion
Stock Option (Right t Buy)
2013-05-31−5,000→ 35,000 totalExercise: $61.60From: 2013-04-11Exp: 2022-10-26→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on April 16, 2013 and 1/36th of the remaining shares will vest monthly thereafter.
- [F2]The option vests 6/48 on April 11, 2013; the remainder vests proportionately on each of April 11, 2014, April 11, 2015 and April 11, 2016. The vesting of the options are subject to satisfaction of certain performance criteria.
Documents
Issuer
PHARMACYCLICS INC
CIK 0000949699
Entity typeother
Related Parties
1- filerCIK 0001559226
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 8:02 PM ET
- Size
- 12.5 KB